tiprankstipranks
Advertisement
Advertisement
Bausch + Lomb says Phase 2 study of BL1107 did not achieve primary endpoint
PremiumThe FlyBausch + Lomb says Phase 2 study of BL1107 did not achieve primary endpoint
20d ago
Bausch + Lomb introduces Orphia AI-powered digital health platform
Premium
The Fly
Bausch + Lomb introduces Orphia AI-powered digital health platform
20d ago
Bausch + Lomb price target raised to $21 from $19 at Citi
Premium
The Fly
Bausch + Lomb price target raised to $21 from $19 at Citi
21d ago
Bausch + Lomb launches Bi-Blade+ dual-port vitrectomy cutter in Europe
PremiumThe FlyBausch + Lomb launches Bi-Blade+ dual-port vitrectomy cutter in Europe
3M ago
Bausch + Lomb Lifts Outlook After Margin-Heavy Quarter
Premium
Company Announcements
Bausch + Lomb Lifts Outlook After Margin-Heavy Quarter
3M ago
Bausch + Lomb price target lowered to $16 from $17 at Evercore ISI
Premium
The Fly
Bausch + Lomb price target lowered to $16 from $17 at Evercore ISI
3M ago
Bausch + Lomb raises FY26 revenue view to $5.420B-$5.530B from $5.375B-$5.475B
PremiumThe FlyBausch + Lomb raises FY26 revenue view to $5.420B-$5.530B from $5.375B-$5.475B
3M ago
Bausch + Lomb announces narrative review on certain B vitamins
Premium
The Fly
Bausch + Lomb announces narrative review on certain B vitamins
3M ago
Bausch + Lomb reports nearly 725k lbs. of eye care materials recycled
Premium
The Fly
Bausch + Lomb reports nearly 725k lbs. of eye care materials recycled
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100